WSJ News Exclusive | Merck in Late-Stage Talks to Acquire Prometheus Biosciences

Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the big drugmaker promising immune disease treatments.

WSJ News Exclusive | Merck in Late-Stage Talks to Acquire Prometheus Biosciences

EDITOR'S PICK

Big BCCI Action After Gambhir, Agarkar’s Concerns; Key Team India Member On Way Out

USC set for revenge showdown with Utah: Takeaways from the Trojans’ win over the Irish

Muslim voters in Illinois were more dissatisfied with major presidential candidates Donald Trump and Kamala Harris in this election, with Gaza the defining issue

You know the real thing when you see Eddie Lopez Bautista

EP NEWSROOM

Unlocking Success: The Journey of Malek Bentchikou, a 23-Year-Old Algerian Trader

Former Dolton officer hired by Munster police despite ‘traumatic’ incidents at past job

Mia Sorety: Houston’s Rising Fitness Influencer Inspires Thousands to Embrace a Healthier Lifestyle

Grayslake data center could become largest county development; water and energy concerns remain

Keep moving in the right direction: Media Agency «Turtle» is calling!

Navigate Site

Welcome Back!

Retrieve your password

WSJ News Exclusive | Merck in Late-Stage Talks to Acquire Prometheus Biosciences

EDITOR'S PICK

EP NEWSROOM

Navigate Site

Follow Us

Welcome Back!

Retrieve your password